Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in: Respiratory Research 1/2020

01-12-2020 | Chronic Obstructive Lung Disease | Letter to the Editor

The ‘can do, do do’ concept in COPD; quadrant interpretation, affiliation and tracking longitudinal changes

Authors: A. J. Alex van ’t Hul, E. H. Noortje Koolen, H. W. Jeroen van Hees, B. Bram van den Borst, M. A. Martijn Spruit

Published in: Respiratory Research | Issue 1/2020

Login to get access

Excerpt

We greatly appreciate the efforts made by Sievi and colleagues to verify our recent findings about the ‘can do, do do’ concept for patients with COPD and expand our understanding on the long-term dynamics of the quadrant affiliation [1, 2]. Since a personalized intervention to improve physical functioning for a patient with COPD may be derived from the quadrant affiliations, interventions should be congruent with the actual ‘can do, do do’ status. We feel challenged, however, to discuss this peer-reviewed paper publicly, with focus on the authors’ interpretation of our findings and two methodological issues. …
Literature
1.
Sievi NA, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, Thurnheer R, Kohler M, Clarenbach CF. “Can do, don’t do” are not the lazy ones: a longitudinal study on physical functioning in patients with COPD. Respir Res. 2020;21:27.CrossRef
2.
Koolen EH, van Hees HW, van Lummel RC, Dekhuijzen R, Djamin RS, Spruit MA, van ‘t Hul AJ. “Can do” versus “do do”: a novel concept to better understand physical functioning in patients with chronic obstructive pulmonary disease. J Clin Med. 2019;8:340.CrossRef
3.
Gimeno-Santos E, Frei A, Steurer-Stey C, de Batlle J, Rabinovich RA, Raste Y, Hopkinson NS, Polkey MI, van Remoortel H, Troosters T, Kulich K, Karlsson N, Puhan MA, Garcia-Aymerich J, consortium PR. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax. 2014;69:731–9.CrossRef
4.
Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14:270–4.CrossRef
5.
Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158:1384–7.CrossRef
6.
Andrianopoulos V, Holland AE, Singh SJ, Franssen FM, Pennings HJ, Michels AJ, Smeenk FW, Vogiatzis I, Wouters EF, Spruit MA. Six-minute walk distance in patients with chronic obstructive pulmonary disease: which reference equations should we use? Chron Respir Dis. 2015;12:111–9.CrossRef
7.
Osadnik CR, Loeckx M, Louvaris Z, Demeyer H, Langer D, Rodrigues FM, Janssens W, Vogiatzis I, Troosters T. The likelihood of improving physical activity after pulmonary rehabilitation is increased in patients with COPD who have better exercise tolerance. Int J Chron Obstruct Pulmon Dis. 2018;13:3515–27.CrossRef
8.
Dolmage TE, Hill K, Evans RA, Goldstein RS. Has my patient responded? Interpreting clinical measurements such as the 6-minute-walk test. Am J Respir Crit Care Med. 2011;184:642–6.CrossRef
9.
Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit MA, Carlin BW, Wanger J, Pepin V, Saey D, Pitta F, Kaminsky DA, McCormack MC, MacIntyre N, Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1447–78.CrossRef
Metadata
Title
The ‘can do, do do’ concept in COPD; quadrant interpretation, affiliation and tracking longitudinal changes
Authors
A. J. Alex van ’t Hul
E. H. Noortje Koolen
H. W. Jeroen van Hees
B. Bram van den Borst
M. A. Martijn Spruit
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2020
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-020-01375-3

Other articles of this Issue 1/2020

Respiratory Research 1/2020 Go to the issue

Research

Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation

Research

Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort

Research

Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis

Research

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

Research

Artificial intelligence accuracy in detecting pathological breath sounds in children using digital stethoscopes

Research

The impact of adjuvant surgical treatment of nontuberculous mycobacterial pulmonary disease on prognosis and outcome
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits